Guardant Health
GH
#1043
Rank
HK$179.74 B
Marketcap
HK$1,339
Share price
-8.83%
Change (1 day)
171.52%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of October 2026 (TTM): 19.4

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -103. At the end of 2026 the company had a P/S ratio of 16.7.

P/S ratio history for Guardant Health from 2018 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202616.724.29%
202513.5164.39%
20245.09-12.59%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Neogen
NEOG
3.00-84.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
21.3 10.19%๐Ÿ‡บ๐Ÿ‡ธ USA